Breast Cancer Stem Cells Express HER2, Even In 'Negative' Tumors, Study Finds

[News]

New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative - and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread...

More... (http://www.medicalnewstoday.com/releases/256927.php)

['lizbeth]

Well . . . duh! Dr. George Peoples already figured that out.

So if you know of anyone diagnosed as a lower expressor, please have them consider this clinical trial:

http://www.clinicaltrials.gov/ct2/show/NCT01570036?term=%22Herceptin%22+and+%22E75%22&rank=1

There are other trials, just for vaccines in progress for lower expressors of Her2

http://www.cancernetwork.com/display/article/10165/1161656